132 related articles for article (PubMed ID: 2825978)
1. Partial reversal of doxorubicin resistance by forskolin and 1,9-dideoxyforskolin in murine sarcoma S180 variants.
Wadler S; Wiernik PH
Cancer Res; 1988 Feb; 48(3):539-43. PubMed ID: 2825978
[TBL] [Abstract][Full Text] [Related]
2. Reversal of doxorubicin resistance by hydrophobic, but not hydrophilic, forskolins.
Wadler S; Yang CP
Mol Pharmacol; 1991 Dec; 40(6):960-4. PubMed ID: 1684637
[TBL] [Abstract][Full Text] [Related]
3. Modulation of cis-diamminedichloroplatinum(II) accumulation and sensitivity by forskolin and 3-isobutyl-1-methylxanthine in sensitive and resistant human ovarian carcinoma cells.
Mann SC; Andrews PA; Howell SB
Int J Cancer; 1991 Jul; 48(6):866-72. PubMed ID: 1713575
[TBL] [Abstract][Full Text] [Related]
4. Selective modulation of vinblastine sensitivity by 1,9-dideoxyforskolin and related diterpenes in multidrug resistant tumour cells.
Shalinsky DR; Heath DD; Jekunen AP; Alcaraz JE; Howell SB
Br J Cancer; 1993 Mar; 67(3):471-9. PubMed ID: 8094975
[TBL] [Abstract][Full Text] [Related]
5. Facilitative actions of the protein kinase-C effector system on hormonally stimulated adenosine 3',5'-monophosphate production by swine luteal cells.
Wheeler MB; Veldhuis JD
Endocrinology; 1989 Nov; 125(5):2414-20. PubMed ID: 2551649
[TBL] [Abstract][Full Text] [Related]
6. Growth factor-induced transcription via the serum response element is inhibited by cyclic adenosine 3',5'-monophosphate in MCF-7 breast cancer cells.
Lowe WL; Fu R; Banko M
Endocrinology; 1997 Jun; 138(6):2219-26. PubMed ID: 9165004
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of 25-hydroxyvitamin D3-24-hydroxylase by forskolin: evidence for a 3',5'-cyclic adenosine monophosphate-independent mechanism.
Mandla S; Tenenhouse HS
Endocrinology; 1992 Apr; 130(4):2145-51. PubMed ID: 1312447
[TBL] [Abstract][Full Text] [Related]
8. Effects of forskolin and analogues on nicotinic receptor-mediated sodium flux, voltage-dependent calcium flux, and voltage-dependent rubidium efflux in pheochromocytoma PC12 cells.
Nishizawa Y; Seamon KB; Daly JW; Aronstam RS
Cell Mol Neurobiol; 1990 Sep; 10(3):351-68. PubMed ID: 1701359
[TBL] [Abstract][Full Text] [Related]
9. Interaction of forskolin with the P-glycoprotein multidrug transporter.
Morris DI; Speicher LA; Ruoho AE; Tew KD; Seamon KB
Biochemistry; 1991 Aug; 30(34):8371-9. PubMed ID: 1679346
[TBL] [Abstract][Full Text] [Related]
10. Hormone-independent activation of adenylate cyclase in large steroidogenic ovine luteal cells does not result in increased progesterone secretion.
Hoyer PB; Fitz TA; Niswender GD
Endocrinology; 1984 Feb; 114(2):604-8. PubMed ID: 6537809
[TBL] [Abstract][Full Text] [Related]
11. Reversal of doxorubicin, etoposide, vinblastine, and taxol resistance in multidrug resistant human sarcoma cells by a polymer of spermine.
Gosland MP; Gillespie MN; Tsuboi CP; Tofiq S; Olson JW; Crooks PA; Aziz SM
Cancer Chemother Pharmacol; 1996; 37(6):593-600. PubMed ID: 8612315
[TBL] [Abstract][Full Text] [Related]
12. Inhibition by forskolin of insulin-stimulated glucose transport in L6 muscle cells.
Klip A; Ramlal T; Douen AG; Bilan PJ; Skorecki KL
Biochem J; 1988 Nov; 255(3):1023-9. PubMed ID: 2463830
[TBL] [Abstract][Full Text] [Related]
13. Forskolin-induced homologous desensitization via an adenosine 3',5'-monophosphate-dependent mechanism(s) in human osteoblast-like SaOS-2 cells.
Fukayama S; Tashjian AH; Bringhurst FR
Endocrinology; 1992 Oct; 131(4):1770-6. PubMed ID: 1327719
[TBL] [Abstract][Full Text] [Related]
14. Verapamil reversal of doxorubicin resistance in multidrug-resistant human myeloma cells and association with drug accumulation and DNA damage.
Bellamy WT; Dalton WS; Kailey JM; Gleason MC; McCloskey TM; Dorr RT; Alberts DS
Cancer Res; 1988 Nov; 48(22):6365-70. PubMed ID: 3180056
[TBL] [Abstract][Full Text] [Related]
15. Isolation of forskolin-resistant adrenal cells defective in the adenylate cyclase system.
Schimmer BP; Tsao J
J Biol Chem; 1984 May; 259(9):5376-9. PubMed ID: 6538878
[TBL] [Abstract][Full Text] [Related]
16. Basal transcriptional activity and cyclic adenosine 3',5'-monophosphate responsiveness of the human cytochrome P450scc promoter transfected into MA-10 Leydig cells.
Hum DW; Staels B; Black SM; Miller WL
Endocrinology; 1993 Feb; 132(2):546-52. PubMed ID: 7678794
[TBL] [Abstract][Full Text] [Related]
17. Forskolin-induced differentiation of cultured rat granulosa cells: new evidence for an intermediary role of adenosine 3',5'-monophosphate in the mechanism of action of follicle-stimulating hormone.
Adashi EY; Resnick CE
Endocrinology; 1984 Jul; 115(1):183-90. PubMed ID: 6329647
[TBL] [Abstract][Full Text] [Related]
18. The regulation of glucose transporter gene expression by cyclic adenosine monophosphate in NIH3T3 fibroblasts.
Hiraki Y; McMorrow IM; Birnbaum MJ
Mol Endocrinol; 1989 Sep; 3(9):1470-6. PubMed ID: 2481819
[TBL] [Abstract][Full Text] [Related]
19. Forskolin potentiation of cholera toxin-stimulated cyclic AMP accumulation in intact C6-2B cells. Evidence for enhanced Gs-C coupling.
Barovsky K; Brooker G
Mol Pharmacol; 1985 Dec; 28(6):502-7. PubMed ID: 3001496
[TBL] [Abstract][Full Text] [Related]
20. Evidence that parathyroid hormone-mediated calcium transport in rat brain synaptosomes is independent of cyclic adenosine monophosphate.
Fraser CL; Sarnacki P; Budayr A
J Clin Invest; 1988 Apr; 81(4):982-8. PubMed ID: 2832450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
